II. Epidemiology
- Availability in Chronic Liver Failure
- Candidates: 18,000 per year for 4000 available livers
- Wait time for Liver Transplantation: 2-3 years
III. Indications: Chronic Liver Failure (Cirrhosis) - Transplant Center Referral
- MELD Score >15 (or significant complications)
- Fulminant Liver Failure
- Decompensated Cirrhosis
-
Hepatocellular Carcinoma
- No single lesion >5 cm
- No more than 3 lesions (largest 3 cm or less)
IV. Indications: Acute Liver Failure - Acetaminophen - Transplant Center Referral (King's College Criteria)
- Option 1: Lab findings after initial Resuscitation (either present)
- Arterial pH <7.3 (after Resuscitation)
- Serum Lactic Acid >3.0 mmol/L
- Option 2: Findings in first 24 hours (all 3 present)
- Hepatic Encephalopathy (Grade 3 or 4)
- INR >6.5
- Serum Creatinine >3.4 mg/dl
- MDCalc
V. Diagnosis: Acute Liver Failure - Non-Acetaminophen - Transplant Center Referral (King's College Criteria)
- Option 1
- Any encephalopathy grade AND INR >6.5
- Option 2
- Any encephalopathy grade AND
- Three of the following criteria
- Age <10 years or >40 years
- Jaundice >7 days before onset of encephalopathy
- INR >3.5
- Serum Bilirubin >=17 mg/dl
- Option 3
- Wilson Disease
- Idiosyncratic Drug Reaction
- Seronegative hepatitis
VI. Contraindications
- Hepatocellular Carcinoma >5 cm
- Other active malignancy
- Active Alcohol Abuse or other Substance Abuse
- Chronic infection
- Advanced cardiopulmonary disease
VII. Efficacy
- One year survival: 85%
- Five year survival: 75%
VIII. Management: Post-transplant care
- Expect on average up to 2 emergency department visits post-transplant (with 70% admission rate)
- Typical post-transplant ED presentations are related to gastrointestinal or infectious symptoms
- Have a low threshold for imaging (CT, Ultrasound) in post-operative transplant symptoms (esp. first year)
IX. Complications
- Transplant Rejection
- Hepatic Ischemia
- Biliary Obstruction
- Drug Reaction or Hypersensitivity
-
Immunocompromised State
- Most intense Immunosuppression in first year after transplant
- High risk for opportunistic infectious complications (e.g. Pneumocystis jiroveci)
X. References
- Swencki (2023) Crit Dec Emerg Med 37(8):4-12